Literature reports suggest that the expression of steroid receptor and aromatase in LG-ESS indicates that adjuvant therapy with progesterone, GnRH analogues, or aromatase inhibitors could be effective (18, 19). This evidence concerns the gene GNRH1 and endometrioid stromal sarcoma.